A Research on Process reengineering under the improvement of the stationary telecommunication corporation’s commercial mode

由于电信重组的实施，电信市场经营格局被彻底打破，电信企业间竞争日趋激烈，传统的经营模式受到严重冲击，调整和改进商务模式成为传统运营企业当务之急。企业必须构建新的作业流程，以适应新的商务模式的建立和竞争的要求。本文对固定电信运营业商务模式改进及流程再造进行了研究。本文在第一章第一节介绍了商务模式的概念、组成部分，以中国网通为例分析了固定电信运营业环境因素，阐述了固定电信运营业商务模式的分类和发展。在第一章第二节引用著作介绍了流程再造概念、内容和方法。在第二章第一节介绍了固定电信运营业商务模式的特点和内容，分析了需改进的动因。在第二章第二节以中国网通为背景对内蒙古锡盟通信分公司作业流程进行了分析。...As a result of application of telecommunication reconstruction, the management of telecommunication market is broken up entirely. The competition among telecommunication corporations become heated day after day. The traditional management pattern is faced with a hard impact, adjustment and improvement of commercial mode become more and more important to traditional corporations. The corporati...学位：工商管理硕士院系专业：管理学院高级经理教育中心（EMBA项目）_高级管理人员工商管理硕士(EMBA)学号：X20031508

Construction and identification of interference plasmid targeting on TNFAIP8

目的:构建并筛选出干扰效率最佳的TnfAIP8-SHrnA-P SIrEn-rETrO Q干扰质粒。方法:通过生物软件选择3个TnfAIP8基因干扰位点,构建干扰质粒并测序验证,将干扰质粒及对照质粒分别转染至A549细胞,通过rT-PCr、WESTErn blOT检测干扰效率。结果:经rT-PCr和WESTErn-blOT证实TnfAIP8-SHrnA-P SIrEn-rETrO Q干扰质粒能有效干扰并抑制细胞内TnfAIP8基因的表达,通过流式检测发现降低TnVAIP8表达可以提高细胞对A dr5SC fV诱导凋亡的敏感性。结论:成功构建和设计了对TnfAIP8基因具有显著干扰效率的干扰质粒,为进一步研究TnfAIP8基因的功能奠定了基础。Objective: To construct and screen the high efficiency interference plasmid of TFAIP8-shRNA-p SIRENRetro Q.Methods: Selected and synthesized three Target Sequence of TNFAIP8 shRNA1,TNFAIP8 shRNA2,TNFAIP8 shRNA3,and construct the TNFAIP8 interference plasmid.Transfection TNFAIP8-shRNA-p SIREN-Retro Q interference plasmid to A549 cells.Filter out the highest interference efficiency plasmid by detecting the mRNA and protein levels using RT-PCR and Western blot methods.Results: We successfully design and built three TNFAIP8-shRNA-p SIREN-Retro Q interference plasmids,and screen out the highest efficiency interference plasmid.Conclusion: Three interference plasmids targeting the TNFAIP8 gene have been constructed successfully and provide a useful tool for studying the function of TNFAIP8.国家自然科学基金项目(81272720); 福建省卫计委医学创新课题(2014-CXB-43); 厦门市科技计划项目(3502Z2083008)资

耐热高活性改进铜基甲醇合成催化剂

耐热高活性改进铜基甲醇合成催化剂Ｈｅａｔ－ｒｅｓｉｓｔａｎｔａｎｄＨｉｇｈｌｙＡｃｔｉｖｅＭｏｄｉｆｉｅｄＣｏｐｐｅｒ－ｂａｓｅｄＣａｔａｌｙｓｔｓｆｏｒＭｅｔｈａｎｏｌＳｙｎｔｈｅｓｉｓ杨意泉，张鸿斌，郭忠平，陈汉忠（厦门大学化学化工学院）周文成，..

抗人DR5单克隆抗体的制备、鉴定及活性分析

目的制备抗人DR5单克隆抗体(mAb),鉴定其特性,并进行生物学活性分析。方法以纯化的可溶性DR5(sDR5)免疫Balb/c小鼠,杂交瘤技术制备抗人DR5mAb;运用ELISA、SDS-PAGE电泳方法测定抗DR5mAb与sDR5结合的特性;Ig亚类ELISA试剂盒鉴定抗DR5mAb亚类;间接ELISA法检测腹水mAb效价;流式细胞仪检测肿瘤细胞表面DR5的表达水平;流式细胞仪检测抗DR5单克隆抗体(mAb)诱导肿瘤细胞凋亡的功能。结果获得1株可分泌抗DR5mAb的杂交瘤细胞系R150。SDS-PAGE电泳检测证实,获得的R150可特异性地识别DR5;R150的Ig亚类为IgGI(λ型);腹水效价为1×106;通过流式细胞仪可敏感地检测到肿瘤细胞表面DR5的表达水平及R150诱导肿瘤细胞凋亡情况。结论获得1株可分泌抗DR5mAb的细胞系R150,抗体具有效价高、特异性强等特点并能有效诱导肿瘤细胞凋亡,具有较好的应用价值

沙溪水污染对微生物群落变化的影响

沙溪是闽江上游3大支流之一.近年来,随着三明市经济的发展,局部污染事件仍时有发生.对沙溪三明河段的细菌、真菌、大肠菌群以及降解污染物的主要微生物进行了数量跟踪,结合COD、总氮和总磷等污染物对沙溪水环境与微生物群落变化的关系进行了初步的研究.结果表明:各种微生物的数量变化与主要的有机污染物值之间存在显著的相关性,所有的相关系数均大于0.7,表明微生物在降解与净化中起着重要的作用,同时对水环境的污染状况具有一定的指示作用;降解有机物的主要微生物的数量于COD显著相关,可作为该河段有机污染物水平的指标;研究结果还显示,三化总口和三农电化口是主要的有机污染点,应加强对这两个位点的监测和排污管理

锂离子电池三元层状氧化物正极材料失效模式分析

镍钴锰三元层状氧化物(NCM)正极材料由于其优越的综合性能在动力/储能电池系统(ESS)领域得到广泛应用。虽然Ni含量的增加可提高三元材料的比容量及电池的能量密度,但相关电池体系的容量保持率和安全性将会变差。如何有效解决该矛盾是此类NCM电池所面临的关键问题。本文从NCM电池体系循环过程中常见的体相结构破坏和正极-电解液界面组成改变两方面失效现象出发,结合近年来国内外对NCM失效模式研究中所提出的新理论、方法、应用,从机械破坏、结构演变、电化学极化、化学副反应、正负极协同效应等多个角度对NCM材料的衰退机理提出见解,对指导电池用户合理制定充放电协议、缓解电动汽车(EV)里程焦虑乃至材料设计本身均有重要的指导及借鉴意义。国家重点研发计划资助（2018YFB0104400,2018YFB0905400

Preventive effect and mechanisms of 3,3-diindolylmethane on oxidative stress induced by hydrogen peroxide in HaCaT cells

目的:探究3,3'-二吲哚甲烷(dIM)对过氧化氢(H_2O_2)诱导人角质形成细胞(HACAT)氧化应激作用的预防效应及可能机制。方法:体外培养HACAT细胞,用H_2O_2建立氧化应激模型。采用CCk-8法检测不同浓度(1~20μMOl/l)dIM对HACAT细胞生长的抑制作用;流式细胞术检测dIM作用前后细胞内活性氧自由基(rOS)含量的变化;WESTErn blOT检测不同浓度dIM(0、5、10μMOl/l)对HACAT氧化应激相关蛋白核因子(nf-κb)和丝裂原活化蛋白激酶(MAPkS)磷酸化表达水平的影响。结果:成功建立了HACAT氧化应激模型。CCk-8法研究结果显示1-10μMOl/l dIM对HACAT细胞无明显毒性作用(P>0.05);流式细胞术检测结果表明10μMOl/l dIM预处理可有效预防由H_2O_2诱导的HACAT内rOS产生(P0.05).Flow cytometry results indicated that pretreatment with DIM(10 μmol/L) could inhibit the level of intracellular ROS(P<0.05).With increasing concentration of DIM,the levels of p-p38-MAPK,p-JNK and p-NF-κB were significantly depressed.CONCLUSION:DIM could protect HaCaT cells from H_2O_2-induced oxidative stress via suppressing production of ROS levels and down-regulating the expression of NF-κB and members of MAPKs.DIM might be used as an effective drug to treat or reduce oxidative stressmediated injury in skin cells.国家自然科学基金青年基金(81101562); 广东省科技计划项目(2012B060300005); 广东省自然科学基金(S2012010009633

Development of aquantitative ELISA detection method for Varicella Zoster Virus(VZV) antigen

目的:建立水痘-带状疱疹病毒(VzV)抗原的双抗体夹心ElISA定量检测方法,用于质控VzV灭活疫苗研发和生产中抗原含量。方法:以VzV中和单抗5f6C8为包被抗体、8H5d1为酶标抗体,构建定量检测VzV抗原的双抗体夹心ElISA方法,并对本方法的特异性、灵敏度、准确性、线性和稳定性等性能进行分析。结果:建立的双抗体夹心定量检测VzV抗原的ElISA方法,线性范围为0.4μg~13μg/Ml,相关系数为r2=0.994,定量限度为0.4μg/Ml;变异系数CV80%。与VzV以外的相关病毒样本没有交叉反应。结论:构建的VzV抗原ElISA定量检测方法的各项性能符合定量检测需要,可用于VzV灭活疫苗的研发和生产过程的抗原含量检测。Objective:To develop a quantitative enzyme linked immunosorbent assay(Q-ELISA) to determine the concentration of Varicella Zoster Virus(VZV) antigen.This method was used to determine VZV antigen content at each stage of VZV inactived vaccine developing and manufacturing process.Methods: A double antibody sandwich Q-ELISA was developed to determine concentration of VZV antigen,which was based on the the high-affinity neutralizing monoclonal antibodies 5F6C8 as capture antibodies,and 8H5D1 as HRP-labeled antibody.The performance of reagent were evaluated.Results: The Q-ELISA for VZV antigen content was successfully developed.The reagent had good performance.The quantitation scope was 0.4 μg~13 μg/ml,The coefficient correlation was 0.994,the limit of detection was 0.4 μg /ml,the recovery was between 87.5% and 111.6%.The stability was up to 80% after reagent was heated for 6 days at 37℃.The variation coefficient was lower than 15%,and the reagent was no reaction with other sample except VZV antigen.Conclusion: The Q-ELISA for VZV antigen was developed with good specificity,accuracy and stability.The method can be used to determine VZV antigen content during development and production of VZV inactived vaccine